Pattern Recognition Receptors and the Inflammasome in Kidney Disease

Overview

Journal Nat Rev Nephrol

Specialty Nephrology

Date 2014 Jun 4

PMID 24890433

Citations 93

Authors

Jaklien C Leemans

Lotte Kors

Hans-Joachim Anders

Sandrine Florquin

Affiliations

Soon will be listed here.

Abstract

Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain receptors (NLRs) are families of pattern recognition receptors that, together with inflammasomes, sense and respond to highly conserved pathogen motifs and endogenous molecules released upon cell damage or stress. Evidence suggests that TLRs, NLRs and the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome have important roles in kidney diseases through regulation of inflammatory and tissue-repair responses to infection and injury. In this Review, we discuss the pathological mechanisms that are related to TLRs, NLRs and NLRP3 in various kidney diseases. In general, these receptors are protective in the host defence against urinary tract infection, but can sustain and self-perpetuate tissue damage in sterile inflammatory and immune-mediated kidney diseases. TLRs, NLRs and NLRP3, therefore, have become promising drug targets to enable specific modulation of kidney inflammation and suppression of immunopathology in kidney disease.

Citing Articles

Anti-Inflammatory Resveratrol Protects Mice From Early Mortality After Haematopoietic Stem Cell Transplantation.

Zhang X, Yu W, Sun Y, Ye X, He Y, Huang X J Cell Mol Med. 2025; 29(3):e70395.

PMID: 39900564 PMC: 11790355. DOI: 10.1111/jcmm.70395.

Renal and Vascular Functional Decline in Aged Low Birth Weight Murine Adults.

Rabadi M, Verde M, Camilliere M, Vecchio N, Kandhi S, Sekulic M Kidney Blood Press Res. 2024; 49(1):1075-1090.

PMID: 39571568 PMC: 11652227. DOI: 10.1159/000542141.

Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease.

Ji Y, Hua H, Jia Z, Zhang A, Ding G Kidney Dis (Basel). 2024; 10(5):369-383.

PMID: 39430292 PMC: 11488838. DOI: 10.1159/000539496.

Renal tubular epithelial cells response to injury in acute kidney injury.

Li Z, Li X, Zhou Y, Wang B, Lv L, Liu B EBioMedicine. 2024; 107:105294.

PMID: 39178744 PMC: 11388183. DOI: 10.1016/j.ebiom.2024.105294.

Erythrocyte membrane biomimetic EGCG nanoparticles attenuate renal injury induced by diquat through the NF-κB/NLRP3 inflammasome pathway.

Qu J, Pei H, Li X, Li Y, Chen J, Zhang M Front Pharmacol. 2024; 15:1414918.

PMID: 39045044 PMC: 11263105. DOI: 10.3389/fphar.2024.1414918.

References

Leemans J, Butter L, Pulskens W, Teske G, Claessen N, van der Poll T . The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One. 2009; 4(5):e5704. PMC: 2682651. DOI: 10.1371/journal.pone.0005704. View

Hagberg L, Hull R, Hull S, McGhee J, Michalek S, Svanborg Eden C . Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun. 1984; 46(3):839-44. PMC: 261623. DOI: 10.1128/iai.46.3.839-844.1984. View

Zhang D, Zhang G, Hayden M, Greenblatt M, Bussey C, Flavell R . A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303(5663):1522-6. DOI: 10.1126/science.1094351. View

Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y . Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia. 2012; 55(8):2256-66. DOI: 10.1007/s00125-012-2578-1. View

Melnikov V, Ecder T, Fantuzzi G, Siegmund B, Lucia M, Dinarello C . Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest. 2001; 107(9):1145-52. PMC: 209282. DOI: 10.1172/JCI12089. View

Kuo M, Patschan D, Patschan S, Cohen-Gould L, Park H, Ni J . Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells. J Am Soc Nephrol. 2008; 19(12):2321-30. PMC: 2588100. DOI: 10.1681/ASN.2007111200. View

Brown H, Lock H, Wolfs T, Buurman W, Sacks S, Robson M . Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol. 2007; 18(6):1732-9. DOI: 10.1681/ASN.2006060634. View

Chassin C, Goujon J, Darche S, du Merle L, Bens M, Cluzeaud F . Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways. J Immunol. 2006; 177(7):4773-84. DOI: 10.4049/jimmunol.177.7.4773. View

Pulskens W, Butter L, Teske G, Claessen N, Dessing M, Flavell R . Nlrp3 prevents early renal interstitial edema and vascular permeability in unilateral ureteral obstruction. PLoS One. 2014; 9(1):e85775. PMC: 3893260. DOI: 10.1371/journal.pone.0085775. View

10.

Anders H, Banas B, Linde Y, Weller L, Cohen C, Kretzler M . Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol. 2003; 14(2):317-26. DOI: 10.1097/01.asn.0000042169.23931.73. View

11.

Sallustio F, De Benedictis L, Castellano G, Zaza G, Loverre A, Costantino V . TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J. 2009; 24(2):514-25. DOI: 10.1096/fj.09-136481. View

12.

Marshak-Rothstein A, Rifkin I . Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol. 2007; 25:419-41. DOI: 10.1146/annurev.immunol.22.012703.104514. View

13.

Tabel Y, Berdeli A, Mir S . Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int J Immunogenet. 2007; 34(6):399-405. DOI: 10.1111/j.1744-313X.2007.00709.x. View

14.

Kruger B, Banas M, Walberer A, Boger C, Farkas S, Hoffmann U . A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci (Lond). 2010; 119(12):535-44. DOI: 10.1042/CS20100190. View

15.

Kumagai Y, Kumar H, Koyama S, Kawai T, Takeuchi O, Akira S . Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells. J Immunol. 2009; 182(7):3960-4. DOI: 10.4049/jimmunol.0804315. View

16.

Devarajan P . Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006; 17(6):1503-20. DOI: 10.1681/ASN.2006010017. View

17.

Anders H, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez De Lema G . Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 2004; 18(3):534-6. DOI: 10.1096/fj.03-0646fje. View

18.

Carneiro L, Magalhaes J, Tattoli I, Philpott D, Travassos L . Nod-like proteins in inflammation and disease. J Pathol. 2007; 214(2):136-48. DOI: 10.1002/path.2271. View

19.

Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, Schmaderer C . Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol. 2010; 25(5):853-60. DOI: 10.1007/s00467-009-1422-4. View

20.

Leemans J, Stokman G, Claessen N, Rouschop K, Teske G, Kirschning C . Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest. 2005; 115(10):2894-903. PMC: 1201659. DOI: 10.1172/JCI22832. View